Trial Outcomes & Findings for Evaluating Immune Response to Seasonal FluMist in Healthy Adults (NCT NCT01673425)

Results Overview

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

5 participants

Primary outcome timeframe

Change from baseline in antibody titer at 6 weeks

Results posted on

2021-01-27

Participant milestones
Measure	Experimental: Live Attenuated Influenza Vaccine Single intervention study; all participants receive LAIV
Overall Study STARTED	5
Overall Study COMPLETED	4
Overall Study NOT COMPLETED	1

Withdrawal data not reported

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Baseline characteristics by cohort
Measure	Live Attenuated Influenza Vaccine Study n=5 Participants This study was terminated due to poor enrollment and inconclusive nasal wash samples. No analyses were performed.
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	5 Participants n=5 Participants
Age, Categorical >=65 years	0 Participants n=5 Participants
Sex: Female, Male Female	4 Participants n=5 Participants
Sex: Female, Male Male	1 Participants n=5 Participants
Region of Enrollment United States	5 participants n=5 Participants

Timeframe: Change from baseline in antibody titer at 6 weeks

Population: This study was terminated due to poor enrollment. Analyses were not conducted due to inconclusive nasal wash samples.

Outcome data not reported

Timeframe: Change from baseline in serum antibody response at 6 weeks

Outcome data not reported

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

VA National Center for Occupational Health & Infection Control

Phone: 352-376-1611